Southeast Clinical Oncology
2150 Country Club Road,
Winston Salem, NC 27104
T: (336) 448-1417
F: (336) 448-1425
Asheville, NC – Messino
Fort Myers, FL
Hampton Roads, VA
Hendersonville, NC – Pardee
Hendersonville, NC – AdventHealth
New Bern, NC
Rocky Mount, NC
Dr. Mohammed Saad Joins Ravenel Cancer Center/in Martinsville
Sovah Health today announced that oncologist Mohammed Saad, MD has joined the Ravenel Cancer Center at Sovah Health’s Martinsville campus. Dr. Saad comes to Sovah Health from Wake Forest Baptist Medical Center (Winston – Salem, NC) where he recently finished a dual fellowship in medical oncology and geriatric medicine.
“We are thrilled to welcome Dr. Saad to our medical staff at Sovah Health,” said Tory Shepherd, Chief Operating Officer (COO) of Sovah Health – Martinsville. “His expertise in oncology and geriatric medicine will help expand our team’s ability to deliver high quality cancer care to our community.”
Dr. Saad attended medical school at American University of Beirut (Beirut, Lebanon) and completed his residency at MedStar Good Samaritan/Union Memorial Hospital (Baltimore, MD). He completed fellowships in medical oncology and geriatric medicine at Wake Forest Baptist Medical Center (Winston – Salem, NC). Dr. Saad is a member of the International Society of Geriatric Oncology, American Geriatrics Society, American Society of Clinical Oncology, and the American Society of Hematology.
Dr. Saad is accepting new patients and referrals at the Ravenel Cancer Center located at 320 Hospital Drive, Martinsville, Virginia. Appointments may be made by calling 276.666.7827. >>READ MORE
Immunotherapy Clinical Trials: Sue Scott’s Story of Survival/in Clinical Trial, Immunology, Martinsville, Personal
What is immunotherapy? Cancer immunotherapy, also known as immuno-oncology, is a form of cancer treatment that uses the power of the body’s own immune system to prevent, control, and eliminate cancer. The focus of immunology research is to develop more effective ways to stimulate innate and adaptive immune responses to human tumors and to translate the most promising novel immunotherapies to cancer patients on clinical trials.
In October of 2011 Sue Scott was diagnosed with Stage 1B2 Cervical Cancer and completed what appeared to be successful treatment. Within 3 months there was evidence of active cancer cells, and her doctors told her that an Immunotherapy Clinical Trial was her only treatment option. See her success story here.